You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科濟藥業-B(02171)獲納入恆生綜指成份股
格隆匯 08-22 18:56

格隆匯8月22日丨科濟藥業-B(02171)宣佈,公司已獲選擇及納入恆生綜合指數的成份股,於2021年9月6日生效。

恆生綜合指數提供一項全面的香港市場指標,涵蓋在香港聯合交易所有限公司主板上市公司總市值最高約95%。恆生綜合指數採用流通市值加權法計算,可以用作發行指數基金、互惠基金及表現量度基準。科濟藥業被納入恆生綜合指數標誌着公司股份已符合資格被選作港股通交易標的,港股通是香港與中國內地資本市場投資者之間的股票買賣與投資的渠道。

董事會認為公司獲納入恆生綜合指數反映資本市場對集團正面業務表現及增長前景的肯定,預期該納入將擴闊公司股東基礎及增加股份流動性,從而提高公司投資價值及在資本市場知名度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account